Literature DB >> 32404900

Longitudinal association between physical activity and blood pressure, risk of hypertension among Chinese adults: China Health and Nutrition Survey 1991-2015.

Qinpei Zou1,2, Huijun Wang1, Chang Su1, Wenwen Du1, Yifei Ouyang1, Xiaofang Jia1, Zhihong Wang1, Gangqiang Ding1, Bing Zhang3.   

Abstract

OBJECTIVES: To examine the effects of physical activity (PA) in adults with or without prehypertension at baseline on systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension risk by gender.
METHODS: A total of 5986 men and 6525 women (≥18 years old) without hypertension-related disease at baseline who attended surveys from China Health and Nutrition Survey (1991-2015) at least twice were selected. In terms of the nested data structure, three-level random intercept growth model and three-level logistic regression were used to estimate the relationship between the PA and SBP/DBP or hypertension risk.
RESULTS: The incidence of hypertension increased from 10.86% in 1991 to 20.34% in 2015, and the median of PA dropped from 408 MET·h/week in 1991 to 104 MET·h/week in 2015. After adjusting confounders, PA in the third and fourth quartiles decreased SBP (by 0.98 and 0.96 mm Hg, p < 0.05) and DBP (by 0.30 and 0.38 mm Hg, p < 0.05), and it reduced the odds of hypertension by 12 and 15% (p < 0.05), compared with PA in the lowest quartile. For normotensive women in the third quartile of PA and prehypertensive women in the fourth quartile of PA, the risk of hypertension was reduced 15 and 22%, compared with women in the lowest quartile of PA.
CONCLUSIONS: Physical activity should be improved to the relatively high level to be effective in controlling blood pressure. Normotensive women had an association between physical activity and SBP, DBP, and the risk of hypertension.

Entities:  

Mesh:

Year:  2020        PMID: 32404900     DOI: 10.1038/s41430-020-0653-0

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  1 in total

1.  [The relationship between physical activity and incident hypertension in rural Chinese].

Authors:  X Y Gong; J C Chen; J X Li; J Cao; D S Hu; C Shen; X F Lu; Z Y Zhou; Z D Liu; X L Yang; J P Huang; S F Chen; D F Gu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2018-06-06
  1 in total
  6 in total

1.  Transportation physical activity and new-onset hypertension: A nationwide cohort study in China.

Authors:  Rui Li; Shaojie Zhang; Qinqin Li; Qiguo Meng; Cheng Zu; Yuanyuan Zhang; Panpan He; Mengyi Liu; Chun Zhou; Ziliang Ye; Qimeng Wu; Sisi Yang; Yanjun Zhang; Chengzhang Liu; Xianhui Qin
Journal:  Hypertens Res       Date:  2022-07-13       Impact factor: 5.528

2.  Serum Uric Acid Might Be Positively Associated With Hypertension in Chinese Adults: An Analysis of the China Health and Nutrition Survey.

Authors:  Yingdong Han; Kaidi Han; Xinxin Han; Yue Yin; Hong Di; Juan Wu; Yun Zhang; Xuejun Zeng
Journal:  Front Med (Lausanne)       Date:  2022-01-05

3.  Serum 25-hydroxyvitamin D might be negatively associated with hyperuricemia in U.S. adults: an analysis of the National Health and Nutrition Examination Survey 2007-2014.

Authors:  Y Han; K Han; Y Zhang; X Zeng
Journal:  J Endocrinol Invest       Date:  2021-08-26       Impact factor: 4.256

4.  Blood Pressure Trajectory and Its Influencing Factors in Chinese Adults: A Cohort Study with Long-Term Follow-Up.

Authors:  Chaoyong Yao; Zhibao Wei
Journal:  Med Sci Monit       Date:  2022-03-31

5.  Association between physical activity energy expenditure and cardiometabolic risk factor clustering among Chinese adults in 2015.

Authors:  Xiaorong Chen; Mei Zhang; Limin Wang; Zhengjing Huang; Wenrong Zhang; Jing Wu
Journal:  Sports Med Health Sci       Date:  2022-04-12

6.  Factors Related to Blood Pressure Response after Community-Based Exercise Program in the Elderly Population.

Authors:  Yi-Pin Wang; Kuo-Wei Tseng; Meng-Hui Lin; Mei-Wun Tsai
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.